Table 1 Summary of clinical and laboratory follow-up for HIV-infected patients on ART
Week | Month | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Appointment | 0 | 2 | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 12 |
Clinical evaluation | † | † | † | † | † | † | † | † | † | † |
TB screening | † | † | † | † | † | † | † | † | † | † |
Adherence check | † | † | † | † | † | † | † | † | † | † |
Hb | † | † | † | Symptom directed | ||||||
ALT | † | † | † | Symptom directed | ||||||
Creatinine | † | Symptom directed | ||||||||
Pregnancy test | † | If indicated | ||||||||
Urinalysis | † | Symptom directed | ||||||||
Fasting lipid profile and glucose | † | Annually for patients on PIs | ||||||||
CD4 count | † | † | † | |||||||
Viral load | Targeted | |||||||||